Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Clover Corporation Limited
  6. Summary
    CLV   AU000000CLV2

CLOVER CORPORATION LIMITED

(CLV)
  Report
Delayed Quote. Delayed Australian Stock Exchange - 01/21 12:10:21 am
1.6 AUD   --.--%
2021CLOVER : Notification regarding unquoted securities - CLV
PU
2021CLOVER : CLV AGM Managing Directors Report FY21
PU
2021Clover Corporation to Seek Acquisitions Opportunities
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
1.69(c) 1.66(c) 1.68(c) 1.6(c) 1.6(c) Last
153 007 165 394 37 058 75 286 48 911 Volume
+1.81% -1.78% +1.20% -4.76% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2022 69,3 M 49,8 M 49,8 M
Net income 2022 8,73 M 6,27 M 6,27 M
Net cash position 2022 2,03 M 1,46 M 1,46 M
P/E ratio 2022 30,5x
Yield 2022 1,21%
Sales 2023 86,9 M 62,4 M 62,4 M
Net income 2023 11,9 M 8,55 M 8,55 M
Net cash position 2023 3,12 M 2,24 M 2,24 M
P/E ratio 2023 22,4x
Yield 2023 2,12%
Capitalization 266 M 192 M 191 M
EV / Sales 2022 3,81x
EV / Sales 2023 3,03x
Nbr of Employees -
Free-Float -
More Financials
Company
Clover Corporation Limited is an Australia-based company, which is engaged in the refining and sale of natural oil. The CompanyÔÇÖs geographical segments include Australia/New Zealand, Asia, Europe and America. The Company is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. It focuses on developing nutrients for use... 
Sector
Food Processing
Calendar
03/23Earnings Release
More about the company
Ratings of Clover Corporation Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about CLOVER CORPORATION LIMITED
2021CLOVER : Notification regarding unquoted securities - CLV
PU
2021CLOVER : CLV AGM Managing Directors Report FY21
PU
2021Clover Corporation to Seek Acquisitions Opportunities
CI
2021CLOVER CORPORATION LIMITED : Ex-dividend day for final dividend
FA
2021PALLA PHARMA : Taps Clover Exec for CFO Role; Shares Slip 3%
MT
2021CLOVER : Ord Minnett rates CLV as Buy
AQ
2021Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 20..
CI
2021Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 ..
CI
2021Clover Corporation Limited Appoints Andrew Allibon as Company Secretary
CI
2021Clover Corporation Limited Announces Resignation of Paul Sherman as Company Secretary
CI
2021Clover Corporation Limited Announces Resignation of Paul Sherman as Chief Financial Off..
CI
2021Clover Corporation Ltd Announces Payment of Interim Dividend for the Half Year Ended Ja..
CI
2021CLOVER CORPORATION LIMITED : Ex-dividend day for interim dividend
FA
2021Australian Shares End Session Up Tracking Wall Street Gains; RBA Stresses Need for Sust..
MT
2021CLOVER : Net Profit Declines 46% in Fiscal Half-Year 2021; Shares Jump 5%
MT
More news
News in other languages on CLOVER CORPORATION LIMITED
2021Palla Pharma confie à un cadre de Clover le poste de directeur financier ; les actions ..
2021Clover Corporation Limited déclare un dividende final entièrement franc pour l'exercice..
2021Clover Corporation Ltd annonce le versement d'un dividende intérimaire pour le semestre..
2021Les actions australiennes terminent la séance en hausse, suivant les gains de Wall Bour..
2021Le bénéfice net de Clover chute de 46 % au cours du premier semestre de l'exercice 2021..
More news
Chart CLOVER CORPORATION LIMITED
Duration : Period :
Clover Corporation Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLOVER CORPORATION LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,60 AUD
Average target price 1,88 AUD
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Peter J. Davey Chief Executive Officer, MD & Executive Director
Andrew Allibon Chief Financial Officer & Secretary
Rupert Harrington Non-Executive Chairman
Glenn Elliott Manager-Research, Quality & Regulatory
David Pierotti Operations Manager
Sector and Competitors
1st jan.Capi. (M$)
CLOVER CORPORATION LIMITED-6.71%192
BY-HEALTH CO., LTD.-2.78%7 030
BALCHEM CORPORATION-11.85%4 813
HERBALIFE NUTRITION LTD.8.38%4 531
THE SIMPLY GOOD FOODS COMPANY-14.77%3 577
MEDIFAST, INC.-8.31%2 223